MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,941 Cr | ₹130,968 Cr | ₹1,453 Cr | ₹129 Cr | ₹10,561 Cr |
What is the latest Profit After Tax of MANKIND PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,941 Cr |
| Mar2024 | ₹130,968 Cr |
| Mar2023 | ₹1,453 Cr |
| Mar2022 | ₹129 Cr |
| Mar2021 | ₹10,561 Cr |
How is Profit After Tax of MANKIND PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,941 Cr | -98.52 | |
| Mar2024 | ₹130,968 Cr | 8,913.86 | |
| Mar2023 | ₹1,453 Cr | 1,023.68 | |
| Mar2022 | ₹129 Cr | -98.78 | |
| Mar2021 | ₹10,561 Cr | - | |
Compare Profit After Tax of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹91,012.1 Cr | 2.3% | 6.7% | -3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.3% |
6.7% |
-3.9% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses